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Abstract
Background: While responsible innovation in health (RIH) suggests that health innovations could be purposefully 
designed to better support health systems, little is known about the system-level challenges that it should address. The 
goal of this paper is thus to document what is known about health systems’ demand for innovations. 
Methods: We searched 8 databases to perform a scoping review of the scientific literature on health system challenges 
published between January 2000 and April 2016. The challenges reported in the articles were classified using the 
dynamic health system framework. The countries where the studies had been conducted were grouped using the human 
development index (HDI). Frequency distributions and qualitative content analysis were performed. 
Results: Up to 1391 challenges were extracted from 254 articles examining health systems in 99 countries. Across 
countries, the most frequently reported challenges pertained to: service delivery (25%), human resources (23%), and 
leadership and governance (21%). Our analyses indicate that innovations tend to increase challenges associated to human 
resources by affecting the nature and scope of their tasks, skills and responsibilities, to exacerbate service delivery issues 
when they are meant to be used by highly skilled providers and call for accountable governance of their dissemination, 
use and reimbursement. In countries with a low and medium HDI, problems arising with infrastructure, logistics and 
equipment were described in connection with challenges affecting procurement, supply and distribution systems. In 
countries with a medium and high HDI, challenges included a growing demand for drugs and new technology and the 
management of rising costs. Across all HDI groups, the need for flexible information technologies (IT) solutions to reach 
rural areas was underscored. 
Conclusion: Highlighting challenges that are common across countries, this study suggests that RIH should aim to 
reduce the cost of innovation production processes and attend not only to the requirements of the immediate clinical 
context of use, but also to the vulnerabilities of the broader system wherein innovations are deployed. Policy-makers 
should translate system-level demand signals into innovation development opportunities since it is imperative to foster 
innovations that contribute to the success and sustainability of health systems.
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Implications for policy makers
• Equity and sustainability challenges of health systems should be proactively addressed. 
• Health policy-makers should translate system-level demand “signals” into innovation development opportunities. 
• Innovation policy-makers should reward technology-based entrepreneurial activities that closely overlap with the challenges of health systems.
• International policy-oriented forums should share lessons about innovations that better respond to system-level challenges. 
Implications for the public
The publics should contribute to the articulation of system-level needs and challenges. They should also be informed about the way equity and 
sustainability challenges are being addressed.
Key Messages 
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Articulating the Health System Demand for Health 
Innovations
Responsible research and innovation (RRI) represents a policy-
oriented endeavour that gained traction particularly in Europe 
as a result of the environmental, social and ethical concerns 
raised by technological developments.1 For von Schomberg, 
RRI is a “transparent, interactive process by which societal 
actors and innovators become mutually responsive to each 
other with a view to the (ethical) acceptability, sustainability 
and societal desirability of the innovation process and its 
marketable products.”2 Following suit to RRI, responsible 
innovation in health (RIH) suggests that health technologies 
could be designed to better support health systems around the 
world by foregrounding innovation development processes 
that are prospective, reflexive, inclusive and dynamically 
responsive to shifting needs and challenges.3,4 Considering the 
extent to which the current ways of developing and bringing to 
market new health technologies are highly capital-intensive5-7 
and induce major inequities, RIH offers a new lens for policy-
makers: it provides them with principles and tools to develop 
the innovations health systems need and thus proactively 
address equity and sustainability issues. 
Since few attempts have been made to articulate what 
system-level challenges RIH should seek to address, the goal 
of this paper is to document in a structured way what is known 
about health systems’ demand for innovations. We performed 
a scoping review of the peer-reviewed scientific literature that 
examined the needs and challenges of health systems around 
the world between January 2000 and April 2016. While we 
reported elsewhere8 the key lessons and knowledge gaps that 
health services and policy researchers should consider, this 
paper digs further into the challenges specifically associated 
to health innovations. 
The paper is comprised of 4 sections. First, we clarify 
the background to our study and introduce our analytical 
framework. Second, we describe the scoping review 
methodology that guided our analysis of an international 
corpus of 254 articles. Third, we present frequency 
distributions of the challenges that were reported in countries 
with a low, medium, high or very high Human Development 
Index (HDI) and examples of the challenges that are common 
across countries. Fourth, acknowledging that policy-makers 
“are faced with tough choices,”4 we clarify how RIH enables 
them to steer innovation towards more equitable and 
sustainable health systems.
Innovation and the Challenges of Health Systems Around the 
World
Since the late 1980s, new health technologies, defined as the 
“application of organized knowledge and skills in the form 
of devices, medicines, vaccines, procedures and systems 
developed to solve a health problem and improve quality 
of lives,”9 have exerted growing pressure on health system 
financing and governance, raised important social and 
ethical concerns and threatened the sustainability of health 
systems.10-13 Health policy-makers increasingly voiced their 
concerns regarding the diffusion of new medical technologies 
as “the enormous challenges and needs confronting healthcare 
systems today make the governance of innovation extremely 
complex.”4 
In response, health services and policy researchers 
generated knowledge on the individual, clinical and 
organizational barriers and facilitators that affect technology 
adoption patterns in primary care and university teaching 
hospitals.14-16 This literature underscores the importance for 
healthcare managers to foster strategic and continuous change 
management, to devise a broad set of integrated innovation 
governance strategies and to actively support the in-house 
production and use of evidence on the effectiveness and cost 
of these new technologies.17-20 Yet, scholars and practitioners 
of health technology assessment (HTA) often document the 
extent to which new technologies are misused or overused, 
emphasizing an “epidemic of waste”: 
there is an inflexion point at which overused therapeutic 
and diagnostic technologies stop benefiting patients and 
only divert healthcare spending toward potentially low-
benefit or unnecessary applications (so-called low value 
care), limiting our ability to provision consistent, broad-
reaching healthcare to society.11
Since 2000, the unparalleled offer of new drugs, devices, 
procedures and information technologies (IT) provoked 
an important quandary for health services and policy 
researchers: the growing inequalities exacerbated by health 
innovations.9,21 On the one hand, poor countries can 
hardly afford the expensive technologies developed for rich 
countries as primary markets.22 On the other hand, access 
to expensive healthcare is frequently compromised in rich 
countries where third-party payers are struggling to adapt 
their cost control strategies to a rapidly expanding supply 
of innovations.23 In publicly funded systems, such strategies 
often aim to rationalise global health expenditures whereas, 
in privately funded systems, they seek to protect, maintain or 
increase the profit margins of health insurers.13 In both cases, 
health innovation is designed for and made available to the 
better off, which partly explains why Gardner and colleagues22 
stress that “innovation systems respond best to the needs of 
those who can afford their outputs.” For these authors, to 
improve access to essential products and services in low and 
middle-income countries, policy-makers should support: 
(1) technological innovation with added societal value “to 
ensure availability of products that are more cost-effective 
than existing interventions” (eg, a frugal drill for orthopedic 
surgery); (2) social innovation “to ensure the distribution 
of essential goods and services” (eg, access based on ability 
to pay); and (3) adaptive innovation “to contextualize the 
adoption of goods and services to local settings” by involving 
providers and communities (eg, a local knowledge translation 
and exchange unit).22 
In view of the complex policy issues raised by new health 
technologies, one may wonder why health services and policy 
researchers have not yet sought to synthesize what is known 
about system-level challenges that innovations should attend 
to in the first place. This is the research gap our paper seeks to 
address by consolidating the lessons that can be learned from 
a literature that is scattered across disciplines (eg, HTA, health 
economics, public management, public health, nursing, 
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etc), geographic regions (industrialized countries, low and 
middle-income countries), patient groups (eg, children, 
women, vulnerable or marginalized groups, etc) and services 
(eg, mental health, primary care, etc). Beyond highlighting 
the problems raised by the supply of new technologies, it is 
important to contribute to a more explicit articulation of the 
demand for innovation from a health system perspective.24 
This entails an analysis that goes beyond the individual 
demand from physicians and patients.
The “dynamic health system” framework of van Olmen 
and colleagues25 is particularly well suited to support a closer 
examination of system-level challenges. For these authors, 
health systems should be understood as dynamic, open systems 
wherein interactions and shifting equilibriums take place 
among 3 broad components: for adequate “service delivery” 
to unfold, proper “leadership and governance” should make 
available the right set of “resources,” which include human 
resources, finances, infrastructure and supplies, knowledge 
and information systems. These key components must also 
adapt to shifting population needs and contexts and align 
with a set of values and principles. Within their framework, 
innovations such as vaccines, medical devices and drugs are 
part of “infrastructure and supplies,” while IT solutions and 
knowledge-based tools such as computerized medical records, 
telecare or patient decision aids fall within “knowledge and 
information systems.” 
Although van Olmen et al25 do not explicitly recognize this 
point, innovations may affect more than one health system 
component simultaneously, as illustrated by the dotted arrows 
in Figure 1. For instance, innovations transform service 
delivery by providing patients and service providers with 
new means to screen, diagnose and treat diseases, thereby 
putting pressure on human resources since their proper 
use may require new sets of expertise and skills.26,27 While 
certain innovations may contribute to alleviate system-level 
challenges, such as telehomecare applications that reduce 
unnecessary emergency visits,28 the growing complexity of 
other innovations may exacerbate existing challenges. For 
instance, though genomics technologies have been developed 
at a rapid pace and some at a lesser cost, their proper 
integration within health systems requires a host of auxiliary 
adaptations in terms of infrastructures, staff training, clinical 
guidelines, patient decision aids, etc. For Lucassen and 
Houlston, to meet future needs in genomics, “comprehensive 
resources with a far more overarching remit will need to be 
developed” in conjunction with the adoption of “automated 
machine learning, support vector machines and other 
technologies to create systematic and efficient mechanisms to 
assess the impact of variants found by genomic sequencing.”29 
As we further explain below, RIH rather suggests to realign 
the purposes of technological development towards equitable 
and sustainable health systems.
The Principles and Processes of Responsible Innovation in 
Health 
In this paper, RIH is understood as a “collaborative endeavour 
wherein stakeholders are committed to clarify and meet a set 
of ethical, economic, social and environmental principles, 
values and requirements when they design, finance, produce, 
distribute, use and discard sociotechnical solutions to address 
the needs and challenges of health systems in a sustainable 
way.”30 The term “sociotechnical” derives from an “innovation 
systems lens,” which “highlights the need to create and 
implement both social and technological solutions.”22 The 
definition of RIH highlights the importance of supporting 
sustainable health systems, which are defined as: (1) affordable 
for patients, families, employers and the government 
acknowledging that “employers and the government 
ultimately rely on individuals as consumers, employees, 
and taxpayers for their resources”; (2) acceptable to “key 
constituents, including patients and health professionals”; 
and (3) adaptable since “health and healthcare needs are not 
static” and health systems “must respond adaptively to new 
diseases, changing demographics, scientific discoveries, and 
dynamic technologies in order to remain viable.”12
While RIH foregrounds issues that are specific to the 
health sector, it builds on many of the principles of RRI. For 
Stilgoe and colleagues,3 RRI should rely on 4 process-oriented 
principles: (1) anticipation of the risks and opportunities of 
innovation; (2) reflexivity towards the value systems and social 
practices in which innovations are embedded; (3) inclusion of 
stakeholders in order to share roles and responsibilities and 
democratize technological choices; and (4) responsiveness to 
unforeseen consequences that may occur along innovation 
trajectories and across innovation ecosystems. Building on 
these principles, Demers-Payette et al4 argued that those 
who develop RIH should seek to: (1) understand the various 
contexts of use in order to identify opportunities for innovation 
as well as the social, ethical and political risks that are likely 
to arise (anticipation); (2) harmonize the value systems and 
practices that govern the context in which innovations are 
produced (the business sector) and used (the health sector) 
(reflexivity); (3) integrate the views of professional and lay 
users and diversified publics into innovation development 
processes (inclusion); and (4) learn how to adapt innovative 
trajectories by responding to emerging views, norms, 
knowledge and regulatory frameworks (responsiveness). 
While these principles are meant to support a prospective, 
reflexive, inclusive and responsive innovation development 
strategy, a consolidated articulation of the demand from 
a health system perspective is lacking. Hence, using the 
Figure 1. Analytical Framework.
Source: Adapted from the more exhaustive framework of van Olmen et 
al.24
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framework depicted in Figure 1, our study’s goal is to document 
and structure key elements of this demand by examining the 
nature, scope and implications of the system-level challenges 
reported in the peer-reviewed literature published between 
2000 and 2016. This is a period during which many innovations 
and structural changes were introduced and thus yields 
precious insights into the challenges RIH should address. 
We chose not to limit our scoping review to certain groups 
of countries. An international analysis seems particularly 
timely since countries such as India, Brazil, South Africa, and 
China have emerged as “world leaders” in the production of 
innovative health products to address important domestic 
health needs.22 This resulted from a rapid consolidation and 
refinement of their national innovation systems, opening up a 
“critical window” where lessons learned around “policies that 
promote both public health and economic development” can 
be shared.22
Methods
Scoping Review Search Strategy and Article Selection Process
Scoping reviews are a specific type of review that aim to 
map existing literature in a broad field of interest. They are 
particularly well suited to rapidly describe what is known in a 
given research area and identifying key lessons and knowledge 
gaps.31,32 
Following the steps described by Levac et al,33 we developed 
our bibliographic search strategy by identifying a set of 
exemplary articles (n = 43) through consultation with experts 
and a structured search on PubMed. This initial set of studies 
was used to refine our final search strategies with the help of 
a scientific library specialist who pretested and executed these 
strategies. 
A total of 8 online bibliographic databases were searched 
in March 2016: PubMed, EMBASE, PsycINFO, International 
Bibliography of the Social Sciences-ProQuest (IBSS), 
Sociological Abstracts-ProQuest, Worldwide Political Science 
Abstracts-ProQuest, Public Affairs Information Service-
ProQuest (PAIS), and Web of Science-SCI, SCII. All database 
searches were limited to a publication date between January 
2000 and April 2016. To be included, papers had to: (1) have 
an abstract; (2) be written in English, French, or Italian; (3) be 
peer-reviewed; and (4) report on health system challenges or 
needs. “Needs” referred to the human, financial or material 
resources that are deemed necessary to improve and sustain 
the functioning of health systems and “challenges” referred 
to “emerging and enduring problems that destabilise the 
current functioning, performance or sustainability of health 
systems.”8 Articles describing specific vertical programs were 
excluded since they focus on a single health condition and 
pursue short- or medium-term objectives. After excluding 
duplicates, 2 reviewers independently screened the abstracts 
against inclusion and exclusion criteria and when necessary 
the full article was retrieved to resolve disagreements. All 
articles that met the inclusion criteria were read by one of the 
authors (FR) to ascertain whether they addressed our study’s 
aim. As per the principles of the scoping review methodology, 
the quality of the studies was not formally assessed.
Collating, Summarizing and Reporting the Results
An Excel file was created to gather information related to: 
(1) the citation of the article (authors, title, year, affiliation of 
the first author); (2) details regarding the nature and scope 
of the article (type of article, objectives, country studied, 
respondents, area of interest, target population); (3) verbatim 
excerpts describing all challenges reported in the article; and 
(4) the category to which referred each of these challenges. 
This dataset thus contains challenges that were reported by 
investigators, not necessarily challenges that are considered 
more important by policy-makers or practitioners.
For each article, we extracted all the reported challenges 
and used a single category to classify each challenge following 
van Olmen and colleagues’ framework. Within each category, 
we developed subcategories to identify the specific challenges 
described by the authors. The coding strategy was refined 
inductively and through discussions with team members. 
The goal was to be able to categorize the challenges as closely 
to the authors’ description as possible, while relying on van 
Olmen and colleagues’ framework to maintain consistency. 
The countries where the studies had been conducted were 
classified along the 2015 HDI, which combines indicators 
relevant to population health: life expectancy at birth, mean 
years of schooling and expected years of schooling, and gross 
national income per capita.34 When health systems in more 
than one country were examined, we only classified the 
articles that pertained to countries belonging to the same 
HDI group. For the specific purposes of this paper, we only 
included the articles that could be classified along the HDI. 
Several research team meetings were carried out during 
the data extraction period and the data charting form was 
updated and modified iteratively. 
Our data analyses combined quantitative and qualitative 
content analysis. First, we established the frequency 
distributions of the challenges to identify what categories and 
subcategories were the most frequently reported within and 
across the HDI groups. Our assumption was that challenges 
that are frequently discussed in the literature may reflect 
important system-level priorities. Second, once the rows 
of the Excel file were sorted according to the HDI groups, 
we performed a qualitative analysis of the verbatim content 
extracted from the articles. This is similar to a “site–ordered 
matrix” analysis35 if one considers the HDI groups as the 
“sites.” This matrix enabled us to systematically look for and 
identify both variations and similarities across our whole 
dataset by comparing how authors explained the nature of 
the challenge being reported, its impact (if any) on other 
system-level challenges and its relationship to innovation. 
For instance, some authors argued that “innovation x” was 
needed to address “challenge a,” whereas others explained that 
“challenge b” was raised by “innovation y.” 
The presentation of our findings is structured around our 
analytical framework (Figure 1) clarifying: what challenges 
were the most frequently reported in countries with a low, 
medium, high or very high HDI; the nature, scope and 
implications of the challenges related to service delivery, 
human resources, and leadership and governance; and the 
more specific challenges raised by infrastructure and supplies 
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(eg, drugs, vaccines, surgical procedures, devices, etc.) and 
knowledge and information systems (eg, IT, telehealth, clinical 
guidelines, HTA, etc). We provide examples of challenges 
from different countries, while avoiding redundancies.
Results
An Overview of the Analyzed Articles 
Figure 2 illustrates the article selection process. After 
exclusion of duplicates and the independent screening of 
4820 abstracts by 2 reviewers, a total of 531 abstracts met 
our inclusion criteria. The full text could not be retrieved 
for 14 of these references and 11 were excluded because the 
articles were not written in English, French, or Italian. A total 
of 506 articles were read by one of the coauthors and 292 
articles were included in the full scoping review. Among these 
articles, 38 could not be classified along the HDI because they 
either examined multiple countries that fell within different 
HDI categories or global challenges. The 254 articles that 
were included in this review reported findings pertaining to 
99 countries.
More than a third of the included studies were formal 
empirical studies (37%) and more than a third (37%) were 
classified as “analyses” since they did not rely on primary 
research. Among the empirical studies, the majority were 
qualitative (63%), while 14% of them applied mixed methods. 
While the majority of the articles examined countries within 
the very high HDI category (60%), in each category there is 
at least one country that is over-represented when compared 
to the others: the United States in the very high HDI category 
(48%); China in the high HDI category (35%); India and 
South Africa in the medium HDI category (29% and 25%); 
and Pakistan in the low HDI category (21%). Table 1 provides 
a summary of the characteristics shared by countries falling 
within each HDI group.
System-Level Challenges Reported Across Countries
A total of 1391 challenges were extracted from the articles. 
Table 2 provides the distribution of these challenges along 
the HDI and van Olmen and colleagues’ 8 broad categories 
of challenges. It shows that the more frequently examined 
challenges across the 4 HDI groups belong to 3 categories: 
health service delivery (25%), human resources (23%), and 
leadership and governance (21%). It also indicates that not 
much research reported on challenges falling within the 
remaining categories: finances (8%), infrastructure and 
supplies (8%), knowledge and information (7%), principles 
and values (6%), and population and context (3%). 
When examining variations across the 4 HDI groups, one 
may observe that 6 challenge categories were reported in 
roughly comparable proportions. Only service delivery and 
human resources present a different pattern where up to 
30% of the challenges reported in countries with a low HDI 
referred to human resources and up to 29% of the challenges 
reported in countries with a very high HDI pertained to 
service delivery. This may reflect the fact that more mature 
health systems manage a larger supply of services whereas 
less mature health systems depend upon the development of 
a qualified workforce. 
Challenges Related to Service Delivery, Human Resources, 
and Leadership and Governance
Table 3 indicates the distribution of the specific challenges 
falling within 3 challenge categories. Those pertaining to 
service delivery include services delivered for the prevention, 
promotion and treatment of acute and chronic conditions. 
It is striking that across the 4 HDI groups the most often 
Figure 2. PRISMA Diagram of the Article Selection Process.
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reported challenges within this category referred to access 
(32%). In countries with a low and medium HDI, the second 
most frequently reported challenges pertained to delivery, 
quality and safety (respectively, 27% and 27%). In countries 
with a high HDI, the second most often reported challenges 
pertained to referral systems and vertical integration (16%), 
whereas in countries with a very high HDI they pertained to 
cultural and linguistic barriers and the difficulty of obtaining 
information about services (19%). 
Our analyses identified many examples where access to 
services was compromised because of geographic, financial 
or sociocultural barriers (see Supplementary file 1). For 
example, in the Mongolian rural areas (high HDI) described 
by Lindskog, the combined effect of these barriers impedes 
“herder families’ ability to access basic healthcare services 
and life-saving medical treatment” because of “long distances 
to health services and lack of transportation; lack of money 
for health insurance; run-down hospitals, unqualified health 
personnel and lack of medical equipment.”37 The need to 
ensure proper access to services increases when caring for 
vulnerable populations. In the United States, Kugel and 
Zoroweste recommended to support “continuity of care and 
tracking for the mobile poor with the use of new technologies 
(cell phones, electronic health records, Internet, virtual case 
management) to ensure follow-up of abnormal tests and 
continuity of treatment regimens for mobile patients.”38 For 
Patterson and Hovey,39 though “it is not surprising” that most 
American primary physicians would be unfamiliar with the 
full range of equipment and therapies available for the large 
number of pediatric chronic health conditions, it limits their 
ability to properly inform parents and impedes continuity of 
care.
As Table 3 indicates, the distribution of the challenges 
related to human resources, which include health service 
providers, health managers and support workers in private 
and public health and social care organizations, varies slightly 
along the HDI: the most frequently reported challenges 
referred to staff distribution and sufficiency (respectively, 
31%, 33%, 29%, and 35%), staff retention, motivations and 
incentives (respectively, 21%, 15%, 30%, and 17%), and staff 
competency and monitoring (respectively, 26%, 15%, 22%, 
and 14%). 
While the availability of staff is dependent upon a country’s 
capacity to train, recruit, retain and support qualified 
personnel, innovations may exacerbate these challenges. In 
a low HDI country like Malawi, Lemay et al40 underscored 
that “a common challenge mentioned by community health 
workers is the delay in receiving up-to-date information 
and the necessary materials for their jobs.” Effective health 
workers have to master the technical knowledge and skills 
required to provide high quality care, but they must also 
possess interpersonal skills to engage in patient-centred care. 
The literature we analyzed indicates that health innovations 
directly affect the former and may indirectly impact the latter. 
For instance, in Russia (high HDI), Sheman and Shishkin41 
observed that “district doctors are not adequately trained in 
modern medical technologies, and as a result, there is a growing 
lack of trust in them, and more and more patients want to 
Table 1. Indicators Related the HDI Groups 
Low HDI
<0.550
Medium HDI
0.550–0.700
High HDI
0.700–0.799
Very High HDI
≥0.800
Life expectancy at birth (y) 59.8 66.6 74.7 79.7
Expected years of schooling 9.4 11.4 14.0 16.1
Mean years of schooling 4.3 6.8 9.5 11.5
Gross national income per capita (PPP $) 3507 6302 14 524 41 491
Main regions
Sub-Saharan 
Africa
South Asia, Arab States
Central Asia, Latin America and The 
Caribbean, East Asia and The Pacific
Europe, North America, 
Other countriesa
Abbreviation: HDI, human development index.
a Australia, Singapore, Japan, South Korea, Israel, Brunei, Cyprus, Qatar, Chile, Saudi Arabia, United Arab Emirates, Argentina, Bahrain, Russia, Kuwait.
Source: UNDP.36
Table 2. Distribution of the System-Level Challenges Reported in the Scientific Articles (n = 254) That Were Classified Along the HDI
Category of challenge
Low HDI Medium HDI High HDI Very High HDI Total
No. % No. % No. % No. % No. %
Health Services Delivery 33 15 33 18 80 26 195 29 341 25
Human resources 68 30 52 28 69 22 124 18 313 23
Leadership and governance 50 22 50 27 61 20 131 20 292 21
Finances 14 6 10 5 29 9 63 9 116 8
Infrastructure and supplies 26 11 17 9 25 8 44 7 112 8
Knowledge and information 25 11 10 5 12 4 49 7 96 7
Principles and values 4 2 9 5 26 8 43 6 82 6
Population and context 7 3 5 3 5 2 22 3 39 3
Total (challenges) 227 100 186 100 307 100 671 100 1391 100
Abbreviation: HDI, human development index.
Note: The 2 shades of grey respectively indicate the first and second most frequently reported challenges.
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receive even simple medical care in hospitals.” Heterogeneous 
work environments also modulate the competency of human 
resources. Canadian home care providers had to adapt to 
“inadequate or unfamiliar technology”42 that reduced their 
ability to properly respond to rural residents’ needs.
The leadership and governance category refers to the 
government’s various roles in health policy ranging from 
policy implementation to community engagement, including 
coordination with private and public organizations whose 
activities impact population health (see Table 3). Across the 
4 HDI groups, the most often reported challenges referred 
to strategic policies and governance (31%), oversight and 
accountability (26%), and horizontal coordination (25%). 
Similar governance issues rested with the development of 
high-level comprehensive health policies that appropriately 
regulate the use of innovations. The lack of policy frameworks 
in Papua New Guinea (low HDI) pushed service providers 
to make rationing decisions “on a day-to-day basis in direct 
clinical care.”43 Melo and Sequeiros44 underscored that 
expanding “appropriate and useful genetic testing” services 
in the Brazilian (high HDI) public health system would 
require “adding effective HTA, ethical meaning, and social 
responsibility to the provision of medical genetics services.” 
In Saudi Arabia (very high HDI), Al-Sharqi and Abdullah45 
described how the regulation of healthcare insurance 
coverage poses equity challenges since regional disparities are 
evident “in resources and infrastructure, medical technology 
and equipment, professional expertise, the quality of care, and 
standards of practices.” 
Effective implementation of health policies requires strong 
horizontal coordination with organizations that operate 
outside the health sector. Chopra et al46 argued that effective 
multisectoral policies must be implemented in South Africa 
(medium HDI) “to target alcohol control, sexual violence and 
inequality, diet and physical activity, hygiene and sanitation, 
and sustainable development.” The capacity of the government 
to play such a broad and strong role was appraised differently 
across countries. For Warsame et al,47 “poor governance in the 
Somali Health System [low HDI] has been symptomatic of the 
breakdown in the wider governance of the country, which has 
been in a state of extreme fragility for more than 2 decades” 
and, as a result, capacity for stewardship was limited. 
While the impacts of a poor regulation of pharmaceuticals 
took different forms across countries (see Supplementary file 
1), the importance of proper oversight and accountability 
mechanisms was similarly underscored. In Somalia (low HDI), 
assessing the quality and authenticity of the drugs brought 
into circulation by the “largely unregulated” pharmaceutical 
industry remains difficult.47 For Yip et al,48 governance 
problems in China (high HDI) are compounded by “collusion 
between providers and the pharmaceutical sector” as certain 
hospitals receive “kickbacks from drug companies for 
prescribing their products” and doctors’ “bonuses are often 
tied to these kickbacks.” 
Table 3. Distribution of the Challenges Specific to Service Delivery, to Human Resources, and to Leadership and Governance
Low HDI Medium HDI High HDI Very High HDI Total
No. % No. % No. % No. % No. %
Service Delivery
Access 7 21 9 27 28 35 64 33 108 32
Delivery, quality, and safety 9 27 9 27 9 11 33 17 60 18
Info, cultural, and linguistic barriers 5 15 4 12 7 9 38 19 54 16
Continuity of care and prevention 5 15 1 3 10 13 25 13 41 12
Referral systems and vertical integration 4 12 6 18 13 16 9 5 32 9
Overuse and waste of resources 1 3 3 9 9 11 13 7 26 8
Waiting times 2 6 1 3 4 5 13 7 20 6
Total (challenges) 33 100 33 100 80 100 195 100 341 100
Human Resources
Staff distribution and sufficiency 21 31 17 33 20 29 43 35 101 32
Retention, motivations, and incentives 14 21 8 15 21 30 21 17 64 20
Competency and monitoring 18 26 8 15 15 22 17 14 58 19
Education and training 10 15 8 15 8 12 15 12 41 13
Provider-patient communication 0 0 7 13 2 3 20 16 29 9
Workload and safety 5 7 4 8 3 4 8 6 20 6
Total (challenges) 68 100 52 100 69 100 124 100 313 100
Leadership and Governance
Strategic policies and governance 16 32 15 30 18 30 41 31 90 31
Oversight and accountability 16 32 15 30 19 31 27 21 77 26
Horizontal coordination 10 20 10 20 13 21 41 31 74 25
Patient and community engagement 5 10 5 10 4 7 14 11 28 10
Regulations 3 6 5 10 7 11 8 6 23 8
Total (challenges) 50 100 50 100 61 100 131 100 292 100
Abbreviation: HDI, human development index.
Note: The 2 shades of grey respectively indicate the first and second most frequently reported challenges.
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Overall, innovations may increase system-level challenges 
that are associated to human resources by affecting the nature 
and scope of their tasks, skills and responsibilities. While they 
raise patients’ expectations, innovations exacerbate service 
access issues when they can only be used by highly skilled 
providers, when their installation and maintenance require 
sophisticated resources or when their integration within 
service delivery affects continuity of care or prohibits their 
system-wide dissemination. As a result, the need for health 
policies that manage expectations and comprehensively 
and accountably regulate the dissemination, use and 
reimbursement of innovations becomes salient.
Challenges Related to Infrastructure and Supplies, and 
Knowledge and Information Systems
Table 4 indicates the distribution of the challenges falling 
within the last 2 categories. The infrastructure and supplies 
category refers to the ‘hardware’ of health systems. In principle, 
to support proper care delivery, infrastructures should be 
accessible by patients, well equipped, well maintained, adapted 
to population needs and include a reliable supply system 
for technologies, drugs and other commodities. Challenges 
pertaining to infrastructure, logistics and equipment were 
the most frequently reported overall (31%). In countries 
with a low and medium HDI, the most frequently reported 
challenges had to do with infrastructure, logistics and 
equipment (respectively, 35% and 41%) and procurement, 
supply and distribution systems (respectively, 46% and 
24%). In contrast, in countries with a high and very high 
HDI, challenges related to the cost of drugs and technologies 
(respectively, 24% and 27%) and to the growing need or 
demand for drugs and technologies (respectively, 24% and 
27%) were more frequently reported. 
Problems related to infrastructure, logistics and equipment 
were described as having diverse consequences (see 
Supplementary file 1), but their sources were intimately 
linked to the challenges raised by the transportation and 
distribution of goods and supplies. In Ethiopia (low HDI), 
Cowan et al49 observed that “pharmacists raised concerns 
regarding medication inventory, describing shortages of 
first-line tuberculosis medications” in several sites and 
noted “regularly receiving medications delivered near or past 
expiration.” In Papua New Guinea (low HDI), an unreliable 
supply of drugs meant both shortages and excesses: “there is 
little stock control and, as a result, facilities are short of some 
items and carry excesses of others.”43 The need to adapt and 
evolve one’s infrastructure in order to adequately address 
current epidemiologic shifts was stressed by Morhason-
Bello and colleagues50 for whom sub-Saharan countries need 
to diagnose and treat cancer. It should be pointed out that 
infrastructure issues were also reported in countries with a 
very high HDI. Cristofalo and colleagues51 studied 2 American 
community health centers in the “urban core of Seattle with 
a rich mix of ethnic and racial diversity and socioeconomic 
disadvantage” and found “physical facility issues, such as 
archaic phone systems, overcrowded waiting rooms, and lack 
of offices for assessments and examinations.”
In countries with a high and very high HDI, the individual 
demand for drugs and new technology was typically discussed 
in light of its financial impact. Merican et al52 underscored 
that “demands for new expensive medications such as anti-
hypertensive drugs and new types of high cost services such 
as transplants and implants and ICT based services, will 
have a significant impact on the limited health resources 
available” in Malaysia (high HDI). In Romania (high HDI), 
such demand was linked to a better-informed citizenry: “the 
increase of the awareness of the citizens-patients in relation 
to the technological development of the diagnostic and 
therapeutic methodologies will contribute to an increase of 
the expectations and demands for top medical services.”53 For 
Peiro and Barrubes,54 the improper use of health technology 
unduly increases health spending in Spain (very high HDI) 
because of “an increase in indications for inappropriate 
medical and surgical procedures, unnecessary pharmaceutical 
Table 4. Distribution of the Challenges Specific to Infrastructure and Supplies, and to Knowledge and Information Systems
Low HDI Medium HDI High HDI Very High HDI Total
No. % No. % No. % No. % No. %
Infrastructure and Supplies
Infrastructure, logistics, and equipment 9 35 7 41 8 32 11 25 35 31
Procurement, supply and distribution systems 12 46 4 24 4 16 5 11 25 22
Costs of drugs and tech 1 4 3 18 6 24 12 27 22 20
Individual need/demand for drugs and tech 0 0 2 12 6 24 12 27 20 18
Quality and efficacy 4 16 1 6 1 4 4 9 10 8
Total (challenges) 26 100 17 100 25 100 44 100 112 100
Knowledge and Information Systems
Information production 9 36 3 30 2 17 11 23 25 26
Information availability 6 24 2 20 3 25 12 24 23 24
Information analysis and sharing 5 20 1 10 3 25 12 24 21 22
Information use 4 16 2 20 3 25 8 16 17 18
Information systems 1 4 2 20 1 8 6 12 10 10
Total (challenges) 25 100 10 100 12 100 49 100 96 100
Abbreviation: HDI, human development index.
Note: The 2 shades of grey respectively indicate the first and second most frequently reported challenges.
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prescriptions, or an increase in the population targeted for 
treatment.” 
As Table 4 indicates, the distribution of challenges associated 
to knowledge and information systems varies moderately 
across countries, with the most frequently reported referring 
to the ability to produce information (26%), to make it 
available to key users (24%), and to analyze and share it 
adequately (22%).
The importance of producing knowledge and supporting 
its use across various health system components in order 
to foster evidence-based management and practice was 
underscored across all HDI groups. For Lemay et al,40 
managers and providers in Malawi (low HDI) would benefit 
from “evidence-based technical and clinical information” if it 
had “local relevance” in terms of context and language and 
included “easy-to-use materials and tools.” According to Ruff 
and colleagues,55 information systems would help to better 
anticipate and adapt to shifting population needs in South 
Africa (medium HDI) by supporting “proactive population 
management.” The proper adoption of new technology was 
associated to the need to build capacity in HTA and support 
evidence-based clinical practices. For instance, Davari et al56 
stressed that Iran (high HDI) had “no systematic method of 
evaluation and guideline creation for the utilization of new 
and high cost technologies.” In a vast country like Canada 
(very high HDI), McGrail et al called for better knowledge 
sharing mechanisms across provinces in order to scale up 
innovations proven effective because “too often” the results of 
“experiments and innovations stay local.”57
Several authors discussed whether IT solutions could 
support the delivery of services. To support mental health 
services in low- and middle-income countries, Hanlon 
and colleagues58 suggested that “peer support or remote 
supervision using telemedicine” need to be considered. In 
the US, Groman and Rubin59 wondered why “despite recent 
investments” in IT solutions, infrastructure and “interoperable 
information technology to support clinical and administrative 
processes” were still not available. Charlton et al28 who 
examined American teleoncology programs for rural cancer 
patients argued that: “broadband internet, necessary for the 
use of modern day, high-quality audiovisual conferencing, is 
less available in rural areas, with residents being more likely to 
report not having broadband access because it is not available 
where they live.” 
Overall, problems arising with infrastructure, logistics 
and equipment were described in countries with a low and 
medium HDI in close connection with local procurement, 
supply and distribution systems. In countries with a medium 
and high HDI, challenges included a growing demand for 
drugs and new technology and the difficulty of managing 
rising costs. Challenges related to knowledge and information 
systems highlight the need for an integrated strategy that 
fosters learning across various health system components and 
mobilizes IT solutions sufficiently flexible to reach remote 
and rural areas. 
Discussion
This paper contributes to fill an important research gap 
by providing an explicit articulation of the system-level 
demand for health innovation. While health services and 
policy scholars frequently underscore that health technology 
constitutes an important cost-driver that needs to be better 
managed,11,13,60 it less often analyzes the ways in which 
innovations may better support health systems. Our goal 
was thus to synthesize and structure the lessons that can be 
learned from an international peer-reviewed literature that is 
scattered across disciplines, geographic regions, patient groups 
and types of services, but which contains rich information 
about the relationships between system-level challenges 
and health innovations. Our scoping review contributes to 
current knowledge by generating novel policy insights into 
the system-level challenges that RIH should address.
What System-Level Challenges Should RIH Address 
RIH “not only calls for the involvement of multiple 
stakeholders, including the publics, but it also argues in 
favour of a deliberate and continuous ex ante consideration 
of what is collectively expected from innovation.”61 Through 
anticipatory, reflexive, inclusive and responsive innovation 
development processes, RIH could enable policy-makers to 
proactively address health system equity and sustainability 
by steering innovation towards these important goals.4,62 Our 
scoping review brings to the fore 5 cross-cutting issues for 
RIH to address. 
First, our findings indicate the prominence of access issues 
across all HDI groups. This is a strong signal for those who 
develop frugal innovations or community-based solutions. 
Access issues may arise when affordability, acceptability or 
geographic accessibility of services is compromised.28,37,51,63,64 
This is exacerbated by the development of sophisticated 
and expensive technologies designed to be used by highly 
skilled providers operating in urban centers.44,65 RIH could 
address such challenges by providing solutions with increased 
affordability, which may result from optimized production 
processes and/or lower maintenance needs. Aiming to reduce 
geographical barriers, several IT solutions were deployed 
throughout the past decades but sometimes failed to define 
how services needed to be concurrently reorganized.15 RIH 
could address such barriers by providing solutions adapted 
to local providers’ needs and constraints, acknowledging 
that increased usability would support their scalability in 
remote or resource-poor settings as well as appropriateness 
and continuity of care.66 Our findings also underscore that 
the need to ensure proper access to services increases when 
caring for vulnerable populations.38,42
Second, RIH should examine whether an innovation may 
increase system-level challenges that are associated to human 
resources by affecting the nature and scope of their tasks, 
skills and responsibilities. Considering that health workers 
with the right skill-mix should be available where and when 
needed,27 RIH should anticipate the intensity of the training 
an innovation may require and how its adoption by providers 
can be supported by their managers. Innovations that require 
less training or training that can be offered locally by peers 
should be prioritized. Our findings show that patients’ views 
about primary care staff and what good care entails may 
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increase pressures on specialized care staff. Hence, RIH could 
support deliberate attempts to reinforce primary care and 
meaningfully inform their patients and the publics about 
screening or diagnostic tests that are known to be useless and 
about what makes a population healthy.20
Third, RIH should consider how existing economic 
incentives affect the governance of privately- and publicly-
funded health systems.45,67,68 In order to reduce health 
inequalities, the ability to benefit from RIH should not vary 
according to one’s socioeconomic status, social position 
or capabilities. While the strengthening of governmental 
capacity is beyond the scope of RIH, our findings suggest 
that RIH should acknowledge that when oversight and 
transparency are compromised in a given health system, 
health innovations may easily become valuable commodities 
in informal or corrupted markets.48,68,69 One key challenge 
for RIH is indeed to anticipate and cope with a complex set 
of regulatory frameworks and market dynamics. Innovation 
scholars, policy-makers and practitioners should explore 
together various scenarios to ensure that proper mitigation 
means are in place for handling the ethical, social and legal 
issues that innovations raise. 
Fourth, our findings highlight that infrastructural 
capacities and distribution systems need to be concurrently 
considered. There are many similarities in the way problems 
with infrastructure and supplies are described in countries 
with a low and medium HDI, ie, in close connection with the 
procurement, supply and distribution of drugs, vaccines and 
equipment. Yet, such challenges are found in rural and remote 
areas across all HDI groups. As such, RIH should carefully 
attend not only to the requirements of the immediate clinical 
context use, but also to the vulnerabilities of the broader 
context in which health innovations are deployed.37 In 
countries with a medium and high HDI, the challenges most 
frequently reported include a growing demand for drugs 
and new technology in parallel with rising costs. To address 
such challenges that are also present in countries with a low 
HDI, RIH could adopt frugal innovation principles in order 
to optimize the fit between an innovation’s performance level 
in terms of functionalities, robustness, durability, etc. and its 
context of use.23 RIH should also forestall business models 
that are mainly geared at generating financial returns to 
shareholders.6,7 Health services and policy researchers as well 
as policy-makers should pay attention to alternative business 
models, which include, for instance, social enterprises that 
reinvest their profits in their mission, adopt redistributive 
pricing schemes or make an innovation freely usable or 
exploitable by others.
Finally, our findings stress the importance of wisely tapping 
into IT-based solutions and supporting evidence-based 
management and practice. This requires considering the links 
between the way information is produced, “packaged” and 
then used. By inclusively engaging managers, clinicians and 
communities, RIH can inform the development of knowledge-
based tools and IT solutions (eg, collaborative platforms, 
patient- and caregiver-oriented tools) whose local adaptation 
can be scaled up across remote and rural areas. Our findings 
show that the need to consider both the broader environment 
At an early stage of innovation development
• Goal: To proactively address the equity and sustainability 
challenges of health systems. 
• Health policy-makers should translate system-level demand 
“signals” into innovation development opportunities that can 
be prioritized by innovation policy-makers. 
• Innovation policy-makers should value, finance and reward 
technology-based entrepreneurial activities that closely 
overlap with the challenges of health systems. 
Throughout the dissemination and use of innovations
• Goal: To foster an inclusive international dialogue on the 
purposes and means of health innovation.
• Industrialized countries should acknowledge the growing 
innovation development capacities of emerging economies.
• Recurrent policy-oriented forums, at the local, regional, 
national and international levels, where researchers, 
practitioners and policy-makers can share lessons about 
innovations that better respond to system-level challenges 
should be established. 
In view of the subsequent cycle of innovation and health policy 
development
• Goal: To use a well-informed system-level demand as a 
continuous lever for innovation.
• Innovation and health policy-makers should remain 
responsive to the evolving needs and expectations of their 
populations.
• They should align their innovation policy actions along a set 
of values and principles that are consistent with the goals of 
health systems.
Box 1. Policy Initiatives to Better Align Health Innovation With System-
Level Challenges
in which health innovations are deployed and their specific 
contexts of use also applies to IT-based services.28,40 This is 
compatible with the increasing willingness of innovative 
companies to “promote open standards, data exchange and 
interoperability in ways that facilitate collaboration across 
suppliers and increase potential for widespread adoption,” 
thereby engaging in “long-term strategic partnerships” with 
health and social care organizations.66
Policy Recommendations
For Greenhalgh et al, current “incentive and regulatory 
mechanisms are not supporting or rewarding the public 
goods” that health systems need.66 This is one of the reasons 
why a stronger command of system-level challenges provides 
innovation policy-makers and health policy-makers with 
precious guidance. While we acknowledge important limits 
to RIH,70 its framework provides these policy-makers with 
principles that could facilitate coordinated action to better 
support the creation and adoption of innovations that bring 
more value to health systems (see Box 1).
First and foremost, health policy-makers should contribute 
to the translation of system-level demand signals into 
innovation development opportunities that can be prioritized 
by innovation policy-makers.10 The latter are responsible for 
various policies (eg, R&D tax credits, economic development 
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strategies, sectorial priorities) that condition, upstream, the 
kinds of innovation that will later be “pushed” towards health 
systems.24 The technology-based entrepreneurial activities 
that are valued, financed and rewarded by innovation 
policy-makers have to closely overlap with system-level 
needs and challenges (eg, IT-mediated community care 
capacity building).6,71 This is particularly important if health 
policy-makers want to proactively address the equity and 
sustainability challenges health systems around the world are 
facing.
Second, it is important to acknowledge that countries 
outside the Organization for Economic Cooperation and 
Development (OECD) are active in health innovation 
development. India, China, Brazil, and South Africa are 
increasingly producing novel scientific and technological 
products.22 One may believe that because these countries 
have very large domestic markets as well as rapidly shifting 
population health needs, they are well positioned to engage in 
the development of RIH. Thus, international policy-oriented 
forums where researchers and policy-makers can regularly 
learn from each other and share lessons about innovations 
that better respond to system-level challenges should be 
encouraged. 
Third, as underscored by van Olmen et al25, to generate 
their expected outcomes and improve health, health systems 
have to adapt to shifting population needs and contexts while 
aligning their priorities along a set of values and principles. 
By emphasizing reflexivity and responsiveness in innovation 
governance mechanisms, RIH could explicitly support and 
account for such alignment. Increasingly, health policy-
makers have to respond to rising patients’ expectations, 
increasingly pluralistic societies and complex reforms that 
include an effective regulation of the private sector. Since 
an important tension between the call to reduce disparities 
in access to services and the control of health spending 
growth was frequently underscored in our corpus of articles, 
a more explicit articulation of the system-level demand for 
innovation may prove a powerful lever for innovation.
Limitations
To our knowledge, this is the first attempt at articulating the 
health system demand for health innovations by carefully 
taking stock of the system-level challenges that have been 
reported in the peer-reviewed international literature. The key 
weaknesses of our scoping review should nonetheless be kept 
in mind. First, our findings reflect the results of our search 
strategy as well as the challenges that various investigators have 
chosen to examine and describe since 2000, not necessarily 
the challenges that are the most important to study or that 
prove the most important in practice. While it is reasonable 
to presume that investigators are influenced by the priorities 
identified by healthcare organizations, research funding 
agencies, managers, practitioners or patients, the absence of 
environmental challenges is intriguing in view of the carbon 
footprint of healthcare that is far from negligible.62 Second, 
although the timeframe we defined for our bibliographic 
search strategy was particularly relevant to capture a period 
marked by the emergence of many innovations, it is possible 
that some of the challenges identified in specific countries 
have been solved since their reporting. This is one of the 
reasons why we focused our analyses on the challenges that 
were recurrent across countries. Third, because the articles 
we reviewed often focused on a particular component of a 
broader national or regional health system (eg, services for 
veterans, indigenous communities, etc), we did not classify 
the types of health system being studied (for instance, the 
Beveridge, Bismarck, national health insurance and out-of-
pocket systems). Lastly, the language restrictions we applied 
contributed to the under-representation of certain countries 
in our corpus of articles (eg, publications in Portuguese, 
Spanish, Japanese, German, etc).
Concluding Remarks
Since the late 1980s, new health technologies not only 
increased global inequalities, but they also undermined the 
sustainability of health systems in rich and poor countries alike. 
For Fineberg,12 successful health systems are characterized 
by: (1) healthy people, that is “a population that attains the 
highest level of health possible”; (2) superior care, which 
entails “effective, safe, timely, patient-centered, equitable, and 
efficient” care; and (3) fairness, which implies that services 
are provided “without discrimination or disparities to all 
individuals and families, regardless of age, group identity, 
or place” and that the “health professionals, institutions, and 
businesses supporting and delivering care” are treated fairly 
within the health system. Along similar lines, we believe that, 
over the next decades, it will be imperative to implement 
policy mechanisms that can support the development, 
financing and use of innovations that do not compromise but 
rather contribute to the success and sustainability of health 
systems. The findings of this scoping review indicate that RIH 
should be steered towards the following key aims: (1) to reduce 
service access barriers (financial, geographic, cultural); (2) to 
match the needs, tasks, skills and responsibilities of health and 
social care providers; (3) to mitigate economic and political 
vulnerabilities affecting health system governance; (4) to 
reduce urban-rural disparities resulting from infrastructural 
capacities and the distribution of goods and supplies across 
regions; and (5) to scale up knowledge- and IT-based tools 
that are adapted to their local context of use.
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